GHEUENS SARAH 1881190 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | 2023-06-30 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 1707.0 | 6.6 | 0.31 | 28.36 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 24159.0 | 55.58 (AGIO) |
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 5750.0 | 22.23 | 1.03 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 25866.0 | 55.58 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-09 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 1789.0 | 6.03 | 0.32 | 22.99 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 27869.0 | 55.89 (AGIO) |
| 2024-01-09 | 2024-01-05 | 2024-01-05 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 5000.0 | 16.86 | 0.89 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 29658.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 5750.0 | 17.1 | 1.03 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 33619.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-24 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 1708.0 | 5.08 | 0.31 | 21.64 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 31911.0 | 55.89 (AGIO) |
| 2024-02-14 | 2024-02-12 | 2024-02-14 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 642.0 | 1.88 | 0.11 | 25.14 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 33431.0 | 55.89 (AGIO) |
| 2024-02-14 | 2024-02-12 | 2024-02-12 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 2162.0 | 6.35 | 0.39 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 34073.0 | 55.89 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 7834.0 | 19.38 | 1.39 | 0.0 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code M | 40415.0
|
56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-05 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 2642.0 | 6.33 | 0.47 | 32.57 | Direct | Common Stock | AGIOS PHARMACEUTICALS, INC. | code S | 39066.0
|
56.19 (AGIO) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | 2023-06-28 | 2023-06-28 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 5750.0 | 50.0 | 1.03 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 5750.0 | 55.58 (AGIO) |
| 2023-09-25 | 2023-09-21 | 2023-09-21 | 4 | Gheuens Sarah | DIRECTOR | acq | 40000.0 | 100.0 | 9.16 | 15.74 | Direct | Stock Option (Right To Buy) | VIRIDIAN THERAPEUTICS, INC.\DE | code A | 40000.0 | 43.67 (VRDN) |
| 2024-01-09 | 2024-01-05 | 2024-01-05 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 5000.0 | 100.0 | 0.89 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-01-24 | 2024-01-20 | 2024-01-20 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 5750.0 | 100.0 | 1.03 | 0.0 | Direct | Performance Share Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-02-14 | 2024-02-12 | 2024-02-12 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 2162.0 | 100.0 | 0.39 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 0.0 | 55.89 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 60000.0 | 100.0 | 10.68 | 32.27 | Direct | Stock Options (Right To Buy) | AGIOS PHARMACEUTICALS, INC. | code A | 60000.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | acq | 17000.0 | 100.0 | 3.03 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code A | 17000.0 | 56.19 (AGIO) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Gheuens Sarah | CHIEF MEDICAL OFFICER | dsp | 7834.0 | 49.48 | 1.39 | 0.0 | Direct | Restricted Stock Units | AGIOS PHARMACEUTICALS, INC. | code M | 8000.0
|
56.19 (AGIO) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)